SEC Form 4 · accession 0001209191-15-006740
ARADIGM CORP · ARDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juergen Kurt Froehlich
Officer — Chief Medical Officer
Period of report
Jan 26, 2015
Accepted (ET)
Jan 27, 2015 · 3:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013238
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $7.70 | Jan 26, 2015 | A | 17,857 | A | — | Jan 26, 2025 | Common Stock | 17,857 | 17,857 | D |
Explanation of responses
- F1Option vests quarterly over three years from the date of grant.
- F2Inapplicable